Background: Racecadotril and Ofloxacin (RACIGYL-O) drug combination are used for the treatment of diarrhea. The drugs have been estimated individually in formulations but no method has been developed for simultaneous estimation of these two drugs as combination.
INTRODUCTION
Combined dosage forms are mostly preferred these days as compared to single dosage forms.
Racecadotril and ofloxacin is available in combined pharmaceutical dosage form. The brand name is Racigyl-O tab containing 100 mg of racecadotril and 200 mg of ofloxacin used in the treatment of diarrhea 1 . Literature survey reveals that various analytical methods have been reported for single dosage forms. The present paper aims to report a simple, accurate, precise, RP-HPLC method for estimation of racecadotril and ofloxacin in combined dosage forms.
Drug profile of Racecadotril
It is chemically known as N-[2-[(acetylthio)methyl]-1-oco-3phenyl-propanoyl)-glycine phenylmethyl ester, which is a prodrug of the enkephalinase inhibitor thiorphan 2 .It is a white powder and freely soluble in methanol and in dichloromethane and practically insoluble in water 3 . It is a (±)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7oxo-2,3-dihydro-7H-pyridol(1,2,3,-de)-1,4-benzoxazine-6carboxylic acid 4 and it is a synthetic broad spectrum antibacterial agent which is official in USP and BP 5 . It acts on DNA gyrase and topoisomerase IV and prevents the excessive supercoiling of DNA during transcription and translation and by inhibiting their function, it inhibits the normal cell divison 6 . It is a pale yellow or bright yellow crystalline powder 6 and it is soluble in glacial acetic acid, and slightly soluble in water, dichloromethane and methanol 3 . Digital pH meter (LI 612 pH analyzer, Elico Ltd., Ahmadabad), were used in the study.
MATERIALS AND METHODS

Optimized chromatographic conditions
Chromatographic condition
The optimal composition of the mobile phase was determined to be acetonitrile, methanol and water pH 2.7 maintained by ortho-phosphoric acid in the ratio (40:40:20 v/v). The mobile phase was filtered through nylon 0.22 μm membrane filters and was degassed to remove the air before use (30 min). Stock solution was prepared by dissolving RAC and OFL (50 mg each) that were weighed accurately and separately transferred into 25 mL volumetric flasks. All the drugs were dissolved in 25 mL of mobile phase to prepare standard stock solutions. After the immediate dissolution, the solution was sonicated and made up the volume with mobile phase. These standard stock solutions were observed to contain 2000mcg/mL of RAC and OFL. Appropriate volume from this solution was further diluted to get appropriate concentration levels according to the requirement. From the stock solutions, dilutions were made in the concentration range of 60, 80, 100, 120, 140µg/mL for RAC and 120, 160, 200, 240, 280µg/mL for OFL.
Preparation of mobile phase
Mobile phase was prepared by mixing acetonitrile (HPLC grade), methanol (HPLC grade) and HPLC water pH 2.7 (40:40:20 v/v). Mixture was shaken vigorously and sonicated for 30 min prior to use.
Preparation of stock solutions
Stock solutions and sample solutions of RAC and OFL and its binary mixture were prepared by adding accurately weighed 50 mg of RAC and OFL separately in 25 mL volumetric flask containing 15 mL of mobile phase. The flasks were then sonicated for 10 min and the volume was made up to the mark by using mobile phase. These standard stock solutions were containing 2000µg/mL of RAC and OFL. Stock solutions were used to prepare desired concentration range as per sample calibration range.
Preparation of Sample solutions
Twenty tablets were weighed and emptied. The equivalent weight was calculated and according to average weight, required drug was taken in volumetric flask to obtain 100mg of RAC and 200mg of OFL in single dilution i.e. according to the label claim of the formulation. The dilutions were first sonicated and then filtered through 0.22 micron filter paper.
Preparation of Calibration curve
The test concentrations for RAC and OFL in HPLC method development were found to be 100µg/mL and 200µg/mL respectively. The calibration curve was prepared by injecting the concentrations of 60-140 µg/mL of RAC and 120-280 µg/mL of OFL in mixture solution manually in triplicate to the HPLC system at detection wavelength of 210 nm. Mean of n=5 determinations was plotted as the standard curve. The calibration curve was tested by validating it with inter-day and intra-day measurements. Linearity, accuracy and precision were performed for both inter-day and intraday measurements.
Method validation
Linearity
The methods were validated according to International Conference on Harmonization Q2B guidelines (2005) for validation of analytical procedures to determine the linearity, sensitivity, precision and accuracy for each analyte. 
Precision and accuracy
Both precision and accuracy were determined with standard quality control samples (in addition to calibration standards) prepared in triplicates at different concentration levels covering the entire linearity range. Precision is defined as a degree of repeatability of an analytical method under normal operational conditions. The precision of the assay was determined by repeatability (intra-day) and intermediate precision (interday) and reported as %R.S.D. for a statistically significant number of replicate measurements. The intermediate precision was carried out by comparing the assays on 3 different days and the results documented as standard deviation and %R.S.D 7 .
Accuracy is the percent of analyte recovered by assay from a known added amount. For the measurement of accuracy, data from nine determinations over three concentration levels covering the specified range were determined. The samples containing 80%, 100%, and 120% of test concentrations were spiked with 100%of standard solution in HPLC and percentage recovery was calculated 8 .
LOD and LOQ
The limit of detection (LOD) is defined as the lowest concentration of an analyte that an analytical process can reliably differentiate from background levels. The limit of quantification (LOQ) is the lowest concentration of the standard curve that can be measured with acceptable accuracy, precision and variability 9 .
The LOD and LOQ were calculated as LOD =3.3σ/S LOQ =10σ/S Where σ is the standard deviation of the lowest standard concentration and S is the slope of the standard curve.
Stability
The stability of RAC and OFL in mobile phase was assessed by analyzing the sample concentrations at 1 h, 4 h, 9 h, 24 h, 48 h and 60 h. The concentrations used in this study were 100µg/mL for RAC and 200µg/mL for OFL prepared from stock solution of pure form and powdered tablet sample, respectively. Six replicate samples for each concentration were assayed at each time point. The stability was tested over a period of three days at room temperature.
Robustness
The effect of intentional variation in analytical conditions such as detection wavelength, mobile phase flow rate and mobile phase composition on the retention time and peak area was investigated one by one.
Analysis of marketed tablets formulation by HPLC
For the assay estimation of marketed formulation by HPLC, Weighed 10 tablets. Accurately weighed powder sample equivalent to 100mg of RAC and 200mg of OFL was dissolved in a 100 mL volumetric flask containing mobile phase. The solution was kept for sonication for 20 min, filtered through Whatmann filter paper No. 41. Aliquot of this solution was diluted to produce the concentration of100µg/mL for RAC and 200µg/mL for OFL. (n= 6).
RESULTS AND DISCUSSION
RP-HPLC spectrophotometric methods were developed for RAC and OFL which can be conveniently employed for routine analysis in pharmaceutical dosage forms and will eliminate unnecessary tedious sample preparations. The chromatographic conditions were optimized in order to provide a good performance of the assay. The retention time of RAC and OFL in tablets formulation were found to be 2.551 min and 4.666 min respectively. The chromatograms have been shown in (Fig3 (a) ). Various system suitability parameters are shown in Table 1 . A five point calibration curve was constructed with working standards and was found linear (r 2 ≥0.998 and 0.997) for RAC and OFL over their calibration ranges. The slopes were calculated using the plot of drug concentration versus area of the chromatogram. The developed HPLC method was accurate, precise, reproducible and very sensitive shown in fig (3 All the method validation parameters are well within the limits as specified in the ICH Q2B guidelines as shown in Table 2 and Table 3 lists the percent recovery (content uniformity) of all the drugs in the commercial formulations by HPLC methods. Moreover the %R.S.D. (less variation)
shows good precision of both developed methods. The calculated LOQ and LOD concentrations confirmed that the methods were sufficiently sensitive. The methods were suitably employed for assaying all the drugs in commercial marketed formulation ( Table 4 ). 
CONCLUSION
Simple, rapid, accurate and precise RP-HPLC methods have been developed and validated for the routine analysis of RAC and OFL in API and capsules dosage forms. The methods are suitable for the simultaneous determination of RAC and OFL in multi-component formulations without interference of each other. The developed methods are suggested for routine and quality control analysis of the investigated drugs in pharmaceutical preparations. The amount found from the proposed methods was in good conformity with the label claim of the formulation. Also the value of standard deviation and coefficient of variation calculated were acceptably low, indicating the suitability of the proposed methods for the routine estimation of tablets dosage forms.
